In a cohort of more than 11,000 patients from the U.K. and Ireland, a comparable proportion of new adalimumab users achieved ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria.

A potential new psoriasis treatment restores the function of certain anti-inflammatory immune cells in a targeted manner.

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small-molecule biosynthetic ...

Initiating methotrexate within 2 years of a psoriasis diagnosis is associated with a reduced risk of progressing to PsA.

"Psoriasis can be a challenging condition to ... a positive trend in reduction of Transepidermal Water Loss (TEWL), a typical phenomenon of psoriatic skin lesions. A poster entitled ...

Medically reviewed by Katlein Franca, MD When psoriasis affects the scalp, it causes thick, silvery-white or gray scales that may be inflamed and itchy. You may also feel burning or other discomfort.

It has been 5 years since the start of the COVID-19 pandemic, which forced many providers to embrace telehealth.In the fall ...